Diadema Partners’s Ocugen OCGN Stock Holding History

Diadema Partners’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$306K	Hold	200,000	–	–	0.04%	125
2026 Q1	$362K	Buy	+200,000	New	+$346K	0.06%	119

Other funds holding OCGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Diadema Partners's OCGN Position: Q2 2026 in Review

Diadema Partners held its Ocugen (OCGN) position steady in Q2 2026 at 200,000 shares worth $306K. The position accounts for 0.04% of the portfolio, ranked #125.

Diadema Partners first reported a position in OCGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $362K in Q1 2026. 148 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

Diadema Partners held 200,000 shares of Ocugen worth $306K as of Q2 2026.
Diadema Partners left its Ocugen share count unchanged in Q2 2026.
Ocugen made up 0.04% of Diadema Partners's portfolio in Q2 2026, its #125 holding.
Diadema Partners first reported a position in Ocugen in Q1 2026 and has held it in 2 quarters since.
Diadema Partners's Ocugen position peaked at $362K in Q1 2026.
148 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.